Table 2.
Autoimmune rheumatic patients (n = 90) | Controls (n = 30) | P Value | |
---|---|---|---|
Composite score | 49.65 ± 20.43 | 79.66 ± 18.19 | < 0.001* |
PCS score | 42.34 ± 22.55 | 81.78 ± 19.11 | < 0.001* |
MCS score | 56.99 ± 23.73 | 77.55 ± 19.26 | < 0.001* |
PF score | 60.56 ± 31.52 | 94.04 ± 10.10 | < 0.001* |
RP score | 21.06 ± 37.08 | 86.54 ± 33.34 | < 0.001* |
BP score | 50.31 ± 29.45 | 84.42 ± 21.92 | < 0.001* |
GH score | 37.44 ± 22.21 | 62.12 ± 25.85 | < 0.001* |
VT score | 58.72 ± 21.10 | 68.85 ± 20.12 | 0.03* |
SF score | 64.86 ± 28.72 | 88.46 ± 18.34 | < 0.001* |
RE score | 39.00 ± 45.23 | 83.33 ± 34.32 | < 0.001* |
MH score | 64.36 ± 21.34 | 69.54 ± 18.10 | 0.26 |
SF-36 Short Form 36-Health Survey, PCS Physical Component Summary, MCS Mental Component Summary, PF Physical Function, RP Role Physical, BP Body Pain, GH General Hhealth, VT Vitality, SF Social Function, RE Role Emotion, MH Mental Health, n number
P value means autoimmune rheumatic patients compared to controls, *P < 0.05